News and Announcements
CEO Dr James Garner speaks about Kazia’s recent milestones with proactive investors
- Published October 09, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Our Chief Executive Officer, Dr James Garner, was interviewed this morning by Proactive Investors on the company’s recent milestones and outlook.
In the interview, Dr Garner discusses:
- Kazia’s recent presentation of new data from the ongoing phase I study of Cantrixil in ovarian cancer at the European Society for Medical Oncology in Barcelona, Spain.
- The company’s recent presentation on its ongoing phase II study of GDC-0084 in glioblastoma at the annual meeting of the European Association of Neuro-Oncology in Lyon, France.
- Kazia’s win of an inaugural ANZLF Trans-Tasman Innovation & Growth Award.
- The recent milestone achieved in Kazia’s study with US-based St Jude’s Children’s Research Hospital in the childhood brain cancer, DIPG.
- The implications of the World Health Organisation selecting a provisional name for Kazia’s lead drug, GDC-0084.
- The upcoming milestones and value catalysts for the company.
Watch the video interview here.
For more information on Kazia register your interest below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
